988 results on '"Hamelmann Eckard"'
Search Results
2. Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study
3. Primary Prevention of Allergic Diseases: Current Concepts and Mechanisms
4. Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts
5. Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study
6. High burden of respiratory allergy in children warrants early identification and treatment with allergen immunotherapy
7. Dupilumab Efficacy and Safety in Children With Moderate to Severe Asthma and High Blood Eosinophils: A Post Hoc Analysis of VOYAGE
8. Research needs in allergy: an EAACI position paper, in collaboration with EFA
9. Impaired resolution of inflammatory response in the lungs of JF1/Msf mice following carbon nanoparticle instillation
10. Pathway focused protein profiling indicates differential function for IL-1B, -18 and VEGF during initiation and resolution of lung inflammation evoked by carbon nanoparticle exposure in mice
11. Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists
12. Characterization of Obesity in Severe Asthma in the German Asthma Net
13. Characterization of Austrian severe asthma patients
14. Neue Leitlinie zur Allergen-Immuntherapie: Was ist für den Pneumologen wichtig
15. German Asthma Net – Was haben wir bisher gelernt?
16. Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort
17. 4/m mit chronischem Schnupfen und Husten: Vorbereitung auf die Facharztprüfung: Fall 97
18. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics
19. The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control
20. German asthma net: Nasal polyposis in patients in the severe asthma registry.
21. Allergische Krankheiten
22. White paper peanut allergy—part 2: Diagnosis of peanut allergy with special emphasis on molecular component diagnostics
23. White paper on peanut allergy – part 1: Epidemiology, burden of disease, health economic aspects
24. Recommendations for asthma monitoring in children:A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO
25. Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study
26. Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI
27. Ingestion of several rubber gloves: A case report on Pica syndrome.
28. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden
29. Development of the Microbiota and Associations With Birth Mode, Diet, and Atopic Disorders in a Longitudinal Analysis of Stool Samples, Collected From Infancy Through Early Childhood
30. Age- and sex-dependent differences in patients with severe asthma included in the German Asthma Net cohort
31. SQ sublingual immunotherapy tablets for children with allergic rhinitis: A review of phase three trials
32. As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort
33. Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study
34. Improved Lung Function is Associated With Better Asthma Control in Children Aged 6 to 11 Years With Moderate-To-Severe Type 2 Asthma: A Post Hoc Analysis of VOYAGE
35. Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA)
36. Health care situation in patients with allergic respiratory diseases with special focus on specific immunotherapy
37. Forced Expiratory Flow (FEF25–75%) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis
38. Comparative Responses in Lung Function Measurements with Tiotropium in Adolescents and Adults, and Across Asthma Severities: A Post Hoc Analysis
39. Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants
40. Tiotropium Is Efficacious in 6- to 17-Year-Olds with Asthma, Independent of T2 Phenotype
41. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy
42. An integrated molecular risk score early in life for subsequent childhood asthma risk.
43. Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children.
44. Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children
45. DUPILUMAB REDUCES RESCUE SYSTEMIC CORTICOSTEROID USE IN CHILDREN WITH UNCONTROLLED MODERATE TO SEVERE ASTHMA REGARDLESS OF PRIOR EXACERBATION HISTORY
46. Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach
47. Allergische Krankheiten
48. Allergische Krankheiten im Kindes- und Jugendalter
49. Correction to “ARIA guideline 2019: treatment of allergic rhinitis in the German health system”
50. 25-Hydroxvitamin D concentrations are not lower in children with bronchial asthma, atopic dermatitis, obesity, or attention-deficient/hyperactivity disorder than in healthy children
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.